Table 1 Clinical and histopathologic characteristics of the patient cohort.

From: Establishing a prognostic model with immune-related genes and investigating EPHB6 expression pattern in breast cancer

 

level

Overall

n

 

58

age (mean SD)

 

53.76 (9.09)

type (%)

DCIS

9 (15.5)

IDC

45 (77.6)

ILC

4 (6.9)

T (%)

Tis

9 (15.5)

1

25 (43.1)

2

24 (41.4)

N (%)

0

40 (69.0)

1

11 (19.0)

2

3 (5.2)

3

4 (6.9)

subtype (%)

Luminal A

21 (36.2)

Luminal B

14 (24.1)

Her2

12 (20.7)

TNBC

11 (19.0)

EPHB6 (%)

1+

21 (36.2)

2+

17 (29.3)

3+

20 (34.5)

  1. DCIS: ductal carcinoma in situ; IDC: invasive ductal carcinoma; ILC: invasive lobular carcinoma; Her2, human epidermal growth factor receptor 2; N, lymph node metastasis; T, tumor size; TNBC, triple negative breast cancer.
Back to article page